Dr Alina Elperin details which medications primary care clinicians should be prepared to prescribe patients with obesity to help prevent cardiovascular disease, here.
"The first thing I want to say about medications is please always conduct a thorough review of the patient's current medications," said Alina Elperin, MD, when asked in a recent interview with Patient Care Online about what type of medications primary care clinicians should be prepared to prescribed to help prevent cardiovascular disease and other complications in patients with obesity. Dr Elperin is an internest and obesity medicine specialist in Evanston, Illinois, as well as a Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine.
In the video below, Dr Elperin discusses what medications to be aware of when reviewing a patient's current medication list and which preventive cardiology therapies can be beneficial in patients with obesity.
Oral PCSK9 Inhibitor Enlicitide Meets All End Points in Phase 3 Hypercholesterolemia Trial
September 2nd 2025At week 24, patients receiving once-daily enlicitide demonstrated statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol compared with placebo.